They also observed a continued increase of CD3+ monocytes, CCR4+ monocytes, CXCR1+ and CXCR3+ T cells in the circulation of MDR-TB patients even after anti-TB treatment that could aid chronicity of infection and delay in recovery46. This evidence concerns the gene CXCR3 and infection.